Nontermal Ablasyon Tedavisi

Aslam MR, Muhammad Asif H, Ahmad K, et al. Global impact and contributing factors in varicose vein disease development. SAGE Open Med 2022; 10: 20503121221118992. 2022/09/03. DOI: 10.1177/20503121221118992.

Eklöf B, Rutherford RB, Bergan JJ, et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. Journal of vascular surgery 2004; 40: 1248-1252.

Carradice D, Mazari F, Samuel N, et al. Modelling the effect of venous disease on quality of life. Journal of British Surgery 2011; 98: 1089-1098.

Gloviczki P, Comerota AJ, Dalsing MC, et al. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2011; 53: 2s-48s. 2011/05/06. DOI: 10.1016/j.jvs.2011.01.079.

Guideline N. Varicose veins in the legs: the diagnosis and management of varicose veins. CG168 2013.

Kerver AL, van der Ham AC, Theeuwes HP, et al. The surgical anatomy of the small saphenous vein and adjacent nerves in relation to endovenous thermal ablation. Journal of vascular surgery 2012; 56: 181-188.

Bakker N, Schieven L, Bruins R, et al. Compression stockings after endovenous laser ablation of the great saphenous vein: a prospective randomized controlled trial. European Journal of Vascular and Endovascular Surgery 2013; 46: 588-592.

Tal MG, Dos Santos SJ, Marano JP, et al. Histologic findings after mechanochemical ablation in a caprine model with use of ClariVein. Journal of Vascular Surgery: Venous and Lymphatic Disorders 2015; 3: 81-85. DOI: https://doi.org/10.1016/j.jvsv.2014.07.002.

Elias S and Raines JK. Mechanochemical tumescentless endovenous ablation: final results of the initial clinical trial. Phlebology 2012; 27: 67-72. 2011/08/02. DOI: 10.1258/phleb.2011.010100.

Whiteley MS, Dos Santos SJ, Lee CT, et al. Mechanochemical ablation causes endothelial and medial damage to the vein wall resulting in deeper penetration of sclerosant compared with sclerotherapy alone in extrafascial great saphenous vein using an ex vivo model. J Vasc Surg Venous Lymphat Disord 2017; 5: 370-377. 2017/04/17. DOI: 10.1016/j.jvsv.2016.12.009.

Boersma D, van Haelst ST, van Eekeren RR, et al. Macroscopic and Histologic Analysis of Vessel Wall Reaction After Mechanochemical Endovenous Ablation Using the ClariVein OC Device in an Animal Model. Eur J Vasc Endovasc Surg 2017; 53: 290-298. 2016/12/28. DOI: 10.1016/j.ejvs.2016.11.024.

Van Eekeren RR, Boersma D, Konijn V, et al. Postoperative pain and early quality of life after radiofrequency ablation and mechanochemical endovenous ablation of incompetent great saphenous veins. Journal of vascular surgery 2013; 57: 445-450.

Alozai T, Huizing E, Schreve M, et al. A systematic review and meta-analysis of mechanochemical endovenous ablation using Flebogrif for varicose veins. Journal of Vascular Surgery: Venous and Lymphatic Disorders 2022; 10: 248-257.e242. DOI: https://doi.org/10.1016/j.jvsv.2021.05.010.

Singhal S and Uthappa MC. Endovascular management of varicose veins: a review of literature. Journal of Clinical Interventional Radiology ISVIR 2019; 3: 098-104.

Sun JJ, Chowdhury MM, Sadat U, et al. Mechanochemical ablation for treatment of truncal venous insufficiency: a review of the current literature. Journal of Vascular and Interventional Radiology 2017; 28: 1422-1431.

Ammollo RP, Petrone A, Giribono AM, et al. Early results of mechanochemical ablation with Flebogrif® in great saphenous vein insufficiency: does polidocanol concentration affect outcome? Translational Medicine@ UniSa 2020; 21: 47.

Vinters HV, Galil KA, Lundie MJ, et al. The histotoxicity of cyanoacrylates. A selective review. Neuroradiology 1985; 27: 279-291. 1985/01/01. DOI: 10.1007/bf00339559.

Almeida JI, Min RJ, Raabe R, et al. Cyanoacrylate adhesive for the closure of truncal veins: 60-day swine model results. Vasc Endovascular Surg 2011; 45: 631-635. 2011/07/16. DOI: 10.1177/1538574411413938.

Proebstle TM, Alm J, Dimitri S, et al. The European multicenter cohort study on cyanoacrylate embolization of refluxing great saphenous veins. J Vasc Surg Venous Lymphat Disord 2015; 3: 2-7. 2015/01/01. DOI: 10.1016/j.jvsv.2014.09.001.

Morrison N, Gibson K, McEnroe S, et al. Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous veins (VeClose). J Vasc Surg 2015; 61: 985-994. 2015/02/05. DOI: 10.1016/j.jvs.2014.11.071.

Gibson K and Ferris B. Cyanoacrylate closure of incompetent great, small and accessory saphenous veins without the use of post-procedure compression: Initial outcomes of a post-market evaluation of the VenaSeal System (the WAVES Study). Vascular 2017; 25: 149-156. 2016/05/22. DOI: 10.1177/1708538116651014.

Koramaz İ, El Kılıç H, Gökalp F, et al. Ablation of the great saphenous vein with nontumescent n-butyl cyanoacrylate versus endovenous laser therapy. J Vasc Surg Venous Lymphat Disord 2017; 5: 210-215. 2017/02/20. DOI: 10.1016/j.jvsv.2016.09.007.

Cabrera J, Cabrera J and Garcí-Olmedo A. Treatment of Varicose Long Saphenous Veins with Sclerosant in Microfoam Form: Long-Term Outcomes. Phlebology 2000; 15: 19-23. DOI: 10.1177/026835550001500103.

Cabrera J, Cabrera J, Jr. and Garcia-Olmedo MA. Sclerosants in microfoam. A new approach in angiology. Int Angiol 2001; 20: 322-329. 2002/01/10.

Cavezzi A, Frullini A, Ricci S, et al. Treatment of Varicose Veins by Foam Sclerotherapy: Two Clinical Series. Phlebology 2002; 17: 13-18. DOI: 10.1177/026835550201700105.

Carugo D, Ankrett DN, Zhao X, et al. Benefits of polidocanol endovenous microfoam (Varithena®) compared with physician-compounded foams. Phlebology 2016; 31: 283-295. 2015/06/04. DOI: 10.1177/0268355515589063.

Asbjornsen CB, Rogers CD and Russell BL. Middle cerebral air embolism after foam sclerotherapy. Phlebology 2012; 27: 430-433. 2012/03/01. DOI: 10.1258/phleb.2011.011002.

Bush RG, Derrick M and Manjoney D. Major neurological events following foam sclerotherapy. Phlebology 2008; 23: 189-192. DOI: 10.1258/phleb.2007.007073.

Leslie-Mazwi TM, Avery LL and Sims JR. Intra-arterial air thrombogenesis after cerebral air embolism complicating lower extremity sclerotherapy. Neurocrit Care 2009; 11: 247-250. 2009/03/19. DOI: 10.1007/s12028-009-9211-2.

Gibson K and Kabnick L. A multicenter, randomized, placebo-controlled study to evaluate the efficacy and safety of Varithena® (polidocanol endovenous microfoam 1%) for symptomatic, visible varicose veins with saphenofemoral junction incompetence. Phlebology 2017; 32: 185-193. 2016/03/26. DOI: 10.1177/0268355516635386.

Aslam MR, Muhammad Asif H, Ahmad K, et al. Global impact and contributing factors in varicose vein disease development. SAGE Open Med 2022; 10: 20503121221118992. 2022/09/03. DOI: 10.1177/20503121221118992.

Eklöf B, Rutherford RB, Bergan JJ, et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. Journal of vascular surgery 2004; 40: 1248-1252.

Carradice D, Mazari F, Samuel N, et al. Modelling the effect of venous disease on quality of life. Journal of British Surgery 2011; 98: 1089-1098.

Gloviczki P, Comerota AJ, Dalsing MC, et al. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2011; 53: 2s-48s. 2011/05/06. DOI: 10.1016/j.jvs.2011.01.079.

Guideline N. Varicose veins in the legs: the diagnosis and management of varicose veins. CG168 2013.

Kerver AL, van der Ham AC, Theeuwes HP, et al. The surgical anatomy of the small saphenous vein and adjacent nerves in relation to endovenous thermal ablation. Journal of vascular surgery 2012; 56: 181-188.

Bakker N, Schieven L, Bruins R, et al. Compression stockings after endovenous laser ablation of the great saphenous vein: a prospective randomized controlled trial. European Journal of Vascular and Endovascular Surgery 2013; 46: 588-592.

Tal MG, Dos Santos SJ, Marano JP, et al. Histologic findings after mechanochemical ablation in a caprine model with use of ClariVein. Journal of Vascular Surgery: Venous and Lymphatic Disorders 2015; 3: 81-85. DOI: https://doi.org/10.1016/j.jvsv.2014.07.002.

Elias S and Raines JK. Mechanochemical tumescentless endovenous ablation: final results of the initial clinical trial. Phlebology 2012; 27: 67-72. 2011/08/02. DOI: 10.1258/phleb.2011.010100.

Whiteley MS, Dos Santos SJ, Lee CT, et al. Mechanochemical ablation causes endothelial and medial damage to the vein wall resulting in deeper penetration of sclerosant compared with sclerotherapy alone in extrafascial great saphenous vein using an ex vivo model. J Vasc Surg Venous Lymphat Disord 2017; 5: 370-377. 2017/04/17. DOI: 10.1016/j.jvsv.2016.12.009.

Boersma D, van Haelst ST, van Eekeren RR, et al. Macroscopic and Histologic Analysis of Vessel Wall Reaction After Mechanochemical Endovenous Ablation Using the ClariVein OC Device in an Animal Model. Eur J Vasc Endovasc Surg 2017; 53: 290-298. 2016/12/28. DOI: 10.1016/j.ejvs.2016.11.024.

Van Eekeren RR, Boersma D, Konijn V, et al. Postoperative pain and early quality of life after radiofrequency ablation and mechanochemical endovenous ablation of incompetent great saphenous veins. Journal of vascular surgery 2013; 57: 445-450.

Alozai T, Huizing E, Schreve M, et al. A systematic review and meta-analysis of mechanochemical endovenous ablation using Flebogrif for varicose veins. Journal of Vascular Surgery: Venous and Lymphatic Disorders 2022; 10: 248-257.e242. DOI: https://doi.org/10.1016/j.jvsv.2021.05.010.

Singhal S and Uthappa MC. Endovascular management of varicose veins: a review of literature. Journal of Clinical Interventional Radiology ISVIR 2019; 3: 098-104.

Sun JJ, Chowdhury MM, Sadat U, et al. Mechanochemical ablation for treatment of truncal venous insufficiency: a review of the current literature. Journal of Vascular and Interventional Radiology 2017; 28: 1422-1431.

Ammollo RP, Petrone A, Giribono AM, et al. Early results of mechanochemical ablation with Flebogrif® in great saphenous vein insufficiency: does polidocanol concentration affect outcome? Translational Medicine@ UniSa 2020; 21: 47.

Vinters HV, Galil KA, Lundie MJ, et al. The histotoxicity of cyanoacrylates. A selective review. Neuroradiology 1985; 27: 279-291. 1985/01/01. DOI: 10.1007/bf00339559.

Almeida JI, Min RJ, Raabe R, et al. Cyanoacrylate adhesive for the closure of truncal veins: 60-day swine model results. Vasc Endovascular Surg 2011; 45: 631-635. 2011/07/16. DOI: 10.1177/1538574411413938.

Proebstle TM, Alm J, Dimitri S, et al. The European multicenter cohort study on cyanoacrylate embolization of refluxing great saphenous veins. J Vasc Surg Venous Lymphat Disord 2015; 3: 2-7. 2015/01/01. DOI: 10.1016/j.jvsv.2014.09.001.

Morrison N, Gibson K, McEnroe S, et al. Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous veins (VeClose). J Vasc Surg 2015; 61: 985-994. 2015/02/05. DOI: 10.1016/j.jvs.2014.11.071.

Gibson K and Ferris B. Cyanoacrylate closure of incompetent great, small and accessory saphenous veins without the use of post-procedure compression: Initial outcomes of a post-market evaluation of the VenaSeal System (the WAVES Study). Vascular 2017; 25: 149-156. 2016/05/22. DOI: 10.1177/1708538116651014.

Koramaz İ, El Kılıç H, Gökalp F, et al. Ablation of the great saphenous vein with nontumescent n-butyl cyanoacrylate versus endovenous laser therapy. J Vasc Surg Venous Lymphat Disord 2017; 5: 210-215. 2017/02/20. DOI: 10.1016/j.jvsv.2016.09.007.

Cabrera J, Cabrera J and Garcí-Olmedo A. Treatment of Varicose Long Saphenous Veins with Sclerosant in Microfoam Form: Long-Term Outcomes. Phlebology 2000; 15: 19-23. DOI: 10.1177/026835550001500103.

Cabrera J, Cabrera J, Jr. and Garcia-Olmedo MA. Sclerosants in microfoam. A new approach in angiology. Int Angiol 2001; 20: 322-329. 2002/01/10.

Cavezzi A, Frullini A, Ricci S, et al. Treatment of Varicose Veins by Foam Sclerotherapy: Two Clinical Series. Phlebology 2002; 17: 13-18. DOI: 10.1177/026835550201700105.

Carugo D, Ankrett DN, Zhao X, et al. Benefits of polidocanol endovenous microfoam (Varithena®) compared with physician-compounded foams. Phlebology 2016; 31: 283-295. 2015/06/04. DOI: 10.1177/0268355515589063.

Asbjornsen CB, Rogers CD and Russell BL. Middle cerebral air embolism after foam sclerotherapy. Phlebology 2012; 27: 430-433. 2012/03/01. DOI: 10.1258/phleb.2011.011002.

Bush RG, Derrick M and Manjoney D. Major neurological events following foam sclerotherapy. Phlebology 2008; 23: 189-192. DOI: 10.1258/phleb.2007.007073.

Leslie-Mazwi TM, Avery LL and Sims JR. Intra-arterial air thrombogenesis after cerebral air embolism complicating lower extremity sclerotherapy. Neurocrit Care 2009; 11: 247-250. 2009/03/19. DOI: 10.1007/s12028-009-9211-2.

Gibson K and Kabnick L. A multicenter, randomized, placebo-controlled study to evaluate the efficacy and safety of Varithena® (polidocanol endovenous microfoam 1%) for symptomatic, visible varicose veins with saphenofemoral junction incompetence. Phlebology 2017; 32: 185-193. 2016/03/26. DOI: 10.1177/0268355516635386.